Drugs / n-3 fatty acids
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00259025 | Sep 2006 → Jul 2007 | chronic renal failure syndrome | Aalborg University Hospital | Completed | No outcome recorded |
| Phase 41 trial · 1 missed | ||||||
| Phase 4 | NCT00772096 | Oct 2008 → Jun 2011 | infectious disease with sepsis | University Hospital, Basel, Switzerland | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | n-3 fatty acids | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00259025 ↗ |